Literature DB >> 30593948

The conformation of chloramphenicol in the ordered and disordered phases.

Emilio Meaurio1, Eva Sanchez-Rexach2, Amaia Butron3, Jose-Ramon Sarasua2.   

Abstract

The conformational behavior of chloramphenicol (CHL) in the solid, liquid and vapor phases is revisited here by means of FTIR spectroscopy and QM methods. In the crystalline phase, both the IR analysis and QM computations discard the conformer proposed by Acharya et al. (Acta Cryst., 1979, B35:1360-1363) and support the one proposed by Chatterjee et al. (J. Cryst. Mol. Struct., 1979, 9:295-304), characterized by an intramolecular OH⋯O hydrogen bond in which the primary hydroxyl group acts as hydrogen bond donor. The conformational behavior of CHL in the liquid and gas phases has been analyzed using QM calculations. The Self-Consistent Reaction Field (SCRF) method with the Onsager solvation model has been used for the initial optimizations in solution, and the lowest energy conformers have been refined using the Solvation Model based on Density (SMD). In solution environment the intramolecular OH⋯O hydrogen bond in CHL is reversed so that the secondary hydroxyl group acts as hydrogen bond donor. In addition, the dichloroacetamide group folds back further over the phenyl ring to form an intramolecular CCl⋯π halogen bond. Two different halogen bonds are actually observed (each one with a different chlorine atom) resulting in two different stable conformers, that can be detected by FTIR spectroscopy due to the conformational sensitivity of the CO group to the conformation of the dichloroacetyl group. Finally, the stability of the conformers with the polarity of the medium is also discussed.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chloramphenicol (CHL); Conformation; Halogen bonding; Hydrogen bonding; Interactions

Mesh:

Substances:

Year:  2018        PMID: 30593948     DOI: 10.1016/j.saa.2018.12.021

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  1 in total

1.  Benefits of Polydopamine as Particle/Matrix Interface in Polylactide/PD-BaSO4 Scaffolds.

Authors:  Naroa Sadaba; Aitor Larrañaga; Gemma Orpella-Aceret; Ana F Bettencourt; Victor Martin; Manus Biggs; Isabel A C Ribeiro; Jone M Ugartemendia; Jose-Ramon Sarasua; Ester Zuza
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.